BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1323775)

  • 1. Prevalence of HCV antibodies in a uraemic population undergoing maintenance dialysis therapy and in the staff members of the dialysis unit.
    Besso L; Rovere A; Peano G; Menardi G; Fenoglio LM; Fenoglio S; Ghezzi PM
    Nephron; 1992; 61(3):304-6. PubMed ID: 1323775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of antibodies against hepatitis C virus in a dialysis unit.
    Cantù P; Mangano S; Masini M; Limido A; Crovetti G; DeFilippo C
    Nephron; 1992; 61(3):337-8. PubMed ID: 1323784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of hepatitis C in a population of hemodialysis patients.
    Mosconi G; Campieri C; Miniero R; Colì L; Orsi C; La Manna G; De Sanctis LB; Stefoni S; Sprovieri G; Bonomini V
    Nephron; 1992; 61(3):298-9. PubMed ID: 1323773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis C infection in a hemodialysis unit.
    Colombo P; Filiberti O; Porcu M; Costantini L; Mangione A; Monzeglio C; Peona C
    Nephron; 1992; 61(3):326-7. PubMed ID: 1323782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus in dialysis units: a multicenter study.
    Da Porto A; Adami A; Susanna F; Calzavara P; Poli P; Castelletto MR; Amici GP; Teodori T; Okolicsanyi L
    Nephron; 1992; 61(3):309-10. PubMed ID: 1323777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second generation assay.
    Mondelli MU; Cristina G; Piazza V; Cerino A; Villa G; Salvadeo A
    Nephron; 1992; 61(3):350-1. PubMed ID: 1323788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to hepatitis C virus (anti-HCV): prevalence in the same geographical area in dialysis patients, staff members, and blood donors.
    Malaguti M; Capece R; Marciano M; Arena G; Luciani MP; Striano M; Biagini M
    Nephron; 1992; 61(3):346. PubMed ID: 1323786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus in hemodialysis patients.
    Dentico P; Volpe A; Buongiorno R; Carlone A; Carbone M; Manno M
    Nephron; 1992; 61(3):307-8. PubMed ID: 1323776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroconversion to hepatitis C virus in dialysis patients: a retrospective and prospective study.
    Medin C; Allander T; Roll M; Jacobson SH; Grillner L
    Nephron; 1993; 65(1):40-5. PubMed ID: 7692314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid.
    Caramelo C; Navas S; Alberola ML; Bermejillo T; Reyero A; Carreño V
    Nephron; 1994; 66(4):470-3. PubMed ID: 7517019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis C virus antibodies in hemodialysis patients in the area of Milan.
    Gubertini G; Scorza D; Beccari M; Buccianti G; Costantino A; Spotti D; Graziani G
    Nephron; 1992; 61(3):271-2. PubMed ID: 1323769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis C antibodies (HCV) in a dialysis population at one center.
    Selgas R; Martinez-Zapico R; Bajo MA; Romero JR; Munoz J; Rinon C; Miranda B; Miguel JL
    Perit Dial Int; 1992; 12(1):28-30. PubMed ID: 1311962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission.
    Conway M; Catterall AP; Brown EA; Tibbs C; Gower PE; Curtis JR; Coleman JC; Murray-Lyon IM
    Nephrol Dial Transplant; 1992; 7(12):1226-9. PubMed ID: 1283447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
    Miyasaka M
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
    Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
    J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C: reality of a renal unit.
    Bracchi O; Orazi E; Lupi GP; Bronzieri C; Cornalba L; Grassi C
    Nephron; 1992; 61(3):369-70. PubMed ID: 1323795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C infection among dialysis patients: a comparison between patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis.
    Chan TM; Lok AS; Cheng IK
    Nephrol Dial Transplant; 1991; 6(12):944-7. PubMed ID: 1724691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCV incidence in a dialysis center: preliminary reports.
    Ippolito E; Aterini S; Salvadori M; D'Elia G; Amato M
    Nephron; 1992; 61(3):375-6. PubMed ID: 1323797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: evaluation of some risk factors.
    Brugnano R; Francisci D; Quintaliani G; Gaburri M; Nori G; Verdura C; Giombini L; Buoncristiani U
    Nephron; 1992; 61(3):263-5. PubMed ID: 1323768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis.
    Huang CC; Wu MS; Lin DY; Liaw YF
    Perit Dial Int; 1992; 12(1):31-3. PubMed ID: 1311963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.